This year's event will once again focus on the clinical benefits of innovative treatment concepts and the discussion of new perspectives in the diagnosis and treatment of gastrointestinal tumors.

The sessions will continue to be organ-based and focus consistently on an interdisciplinary and multidisciplinary approach. In addition to established procedures, current developments in tumor diagnostic research will also be discussed - including immuno-oncological strategies, targeted inhibitors and the management of therapy-associated complications. In addition, "tumor-agnostic" concepts, which are becoming increasingly important, will once again be addressed.

A central highlight will be the oncology hotspot, where current study data from international congresses will be summarized and discussed with regard to their relevance for clinical practice.